30 Country In Vitro Diagnostic (IVD) Market Atlas 2023: Geographic Research and Analysis Focused at a Country Level – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “30 Country In Vitro Diagnostic (IVD) Market Atlas” report has been added to ResearchAndMarkets.com’s offering.

In Vitro Diagnostics (IVD) is a global market. To keep up, the analyst offers geographic research and analysis focused at the country, rather than the regional level in our 30 Country In Vitro Diagnostics (IVD) Market Atlas.

This quarterly updated report contains IVD markets aligned to the global expert estimates in the Worldwide Market for In Vitro Diagnostics, segmented for 30 important country markets and for 19 key test segments.

Global country market coverage includes:

Australia

Austria

Belgium

Brazil

Canada

Chile

China

Egypt

France

Germany

India

Indonesia

Italy

Japan

Mexico

Netherlands

Poland

Romania

Russia

Saudi Arabia

South Africa

South Korea

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

United States

Vietnam

For each of these countries, key market segments include:

Blood Bank Immuno

Blood Bank NAT

Chemistry

Coagulation

COVID-19

Critical Care

FOB

Glucose

Hematology

Histology/Cytology

ID/AST Microbiology

Immunoassays

Immunoassays, Micro

Molecular, Micro

Molecular, Others

Overall Country IVD

Point of Care

POC Infectious Disease

Pregnancy Testing

For more information about this report visit https://www.researchandmarkets.com/r/5pwwcr

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.